To include your compound in the COVID-19 Resource Center, submit it here.

NeuroVia raises $14M in series A

Rare disease company NeuroVia Inc. (San Francisco, Calif.) raised $14 million in a series A

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE